Wade G W & Inc Amgen Inc Transaction History

Wade G W & Inc

$3.08 Billion
Q4 2023

A detailed history of Wade G W & Inc transactions in Amgen Inc stock. As of the latest transaction made, Wade G W & Inc holds 80,162 shares of AMGN stock, worth $25 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

80,162

Previous 78,762 1.78%

Holding current value

$25 Million

Previous $21.2 Million 9.07%

% of portfolio

0.75%

Previous 0.79%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $357,980 - $403,844	1,400 Added 1.78%	80,162 $23.1 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $293,209 - $364,027	1,341 Added 1.73%	78,762 $21.2 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $260,552 - $308,097	-1,216 Reduced 1.55%	77,421 $17.2 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $166,181 - $202,547	736 Added 0.94%	78,637 $19 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $175,207 - $222,622	-765 Reduced 0.97%	77,901 $20.5 Million

Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $165,875 - $187,077	739 Added 0.95%	78,666 $17.7 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $92,976 - $103,466	403 Added 0.52%	77,927 $19 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $378,679 - $418,918	1,727 Added 2.28%	77,524 $18.7 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $357,387 - $408,997	-1,797 Reduced 2.32%	75,797 $17.1 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $227,765 - $266,855	1,073 Added 1.4%	77,594 $16.5 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $138,512 - $153,670	-593 Reduced 0.77%	76,521 $18.7 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $1.05 Million - $1.22 Million	4,710 Added 6.51%	77,114 $19.2 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $1.22 Million - $1.45 Million	5,634 Added 8.44%	72,404 $16.6 Million
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $174,110 - $193,624	-742 Reduced 1.1%	66,770 $17 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $269,021 - $330,126	-1,360 Reduced 1.97%	67,512 $15.9 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $1.06 Million - $1.41 Million	5,815 Added 9.22%	68,872 $14 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $840,092 - $1.08 Million	4,440 Added 7.57%	63,057 $15.2 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $35,170 - $42,141	202 Added 0.35%	58,617 $11.3 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $4.09 Million - $4.8 Million	-24,563 Reduced 29.6%	58,415 $10.8 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $4.2 Million - $4.73 Million	23,212 Added 38.84%	82,978 $15.8 Million
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $197,667 - $230,741	1,108 Added 1.89%	59,766 $11.6 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $1.66 Million - $1.87 Million	8,942 Added 17.99%	58,658 $12.2 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $237,371 - $277,398	1,401 Added 2.9%	49,716 $8.48 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $9,958 - $11,126	59 Added 0.12%	48,315 $8.4 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $8.07 Million - $9.22 Million	48,256	48,256 $9 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.

Account